The Patent Finder

AbbVie Research B.V.

Also on record
Records under this name other than patents AbbVie Research B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to AbbVie Research B.V.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,688,749Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect
Lapsed on the fee record
Ended Jun 27, 2021 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2021USPTO record
US 8,435,523Antibodies against nerve growth factor (NGF) with enhanced in vivo stability
Lapsed on the fee record
Ended May 7, 2021 · USPTO record
Lapsed on the fee recordEnded May 7, 2021USPTO record
US 9,447,181Antibodies against nerve growth factor (NGF) with enhanced in vivo stability
Lapsed on the fee record
Ended Sep 20, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 20, 2020USPTO record
US 8,257,710Method for the treatment of pain with humanized anti-nerve growth factor antibodies
Lapsed on the fee record
Ended Sep 4, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 4, 2020USPTO record
US 8,246,956Humanized anti-nerve growth factor antibodies
Lapsed on the fee record
Ended Aug 21, 2020 · USPTO record
Lapsed on the fee recordEnded Aug 21, 2020USPTO record
US 8,877,491Polynucleotides encoding humanized anti-NGF antibodies
Lapsed on the fee record
Ended Nov 4, 2018 · USPTO record
Lapsed on the fee recordEnded Nov 4, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited